T lymphocytes can be genetically modified to recognize antigens of NSCLC cells, like EGFR, PD-L1, mesothelin, mucin 1, and CEA (Qu et al., 2021[70]; Chen et al., 2022[10]). This evidence concerns the gene EGFR and non-small cell lung carcinoma.